Biotech May Be the Next U.S.-China Battleground
The U.S.-China relationship has gotten so bad that the market assumes the worst whenever a whiff of escalating tensions wafts through the news. The latest victim: Chinese biotech companies.
Related Knowledge Center: Biotechnology: overview
Roundup of developments in biotechnology industries and policymaking.